Skip to content
Subscriber Only

Drugmakers Turn Heat on Insurers by Backing Copay Limits

Updated on

The battle over soaring U.S. drug prices is heading for the states.

With the price of some treatments topping $100,000, patient groups are pushing for state laws to make sure insurers cover most of the costs. Their campaign is backed by an important ally: the drug industry.